Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meral Beksac

Showing results (21-30 of 185) with videos related to

Pageof 19
Sort By:
Case Reports in Medicine|July 20, 2012
Myeloma as a Second Malignancy following AML: Is a Second Allo Equivalent to Auto?Sule Mine Bakanay, Esin Serbest, Klara Dalva, et al.
Chemical Biology & Drug Design|April 24, 2023
HIV-1 integrase inhibitor raltegravir promotes DNA damage-induced apoptosis in multiple myelomaDilara Akcora-Yildiz, Nurbanu Gonulkirmaz, Tulin Ozkan, et al.
Leukemia & Lymphoma|September 14, 2004
Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survivalIsinsu Kuzu, Meral Beksac, Mutlu Arat, et al.
Respirology (Carlton, Vic.)|November 8, 2007
High CD95 expression of BAL lymphocytes predicts chronic course in patients with sarcoidosisOzlem Kumbasar Ozdemir, Gokhan Celik, Klara Dalva, et al.
Molecular Biology Reports|December 14, 2022
Werner helicase is required for proliferation and DNA damage repair in multiple myelomaDilara Akcora-Yildiz, Tulin Ozkan, Mehmet Ozen, et al.
Haematologica|December 6, 2006
Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myelomaKa Lung Wu, Meral Beksac, Jan van Droogenbroeck, et al.
Annals of Hematology|October 6, 2011
Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patientsPervin Topcuoglu, Mutlu Arat, Muhit Ozcan, et al.
Leukemia & Lymphoma|June 14, 2003
The detection of flow cytometric G-CSF receptor expression and it's effect on therapy in acute myeloid leukemiaSim Kutlay, Meral Beksac, Klara Dalva, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 21, 2006
Does continuous flow apheresis influence viability in allogeneic hematopoietic stem cell harvest?Sule Mine Bakanay, Klara Dalva, Mutlu Arat, et al.
Dermatology (Basel, Switzerland)|February 21, 2008
Vitiligo after hematopoietic cell transplantation: six cases and review of the literatureHatice Sanli, Bengu Nisa Akay, Mutlu Arat, et al.
Pageof 19

Showing results (21-30 of 185) with videos related to

Sort By:
Pageof 19
Case Reports in Medicine|July 20, 2012
Myeloma as a Second Malignancy following AML: Is a Second Allo Equivalent to Auto?Sule Mine Bakanay, Esin Serbest, Klara Dalva, et al.
Chemical Biology & Drug Design|April 24, 2023
HIV-1 integrase inhibitor raltegravir promotes DNA damage-induced apoptosis in multiple myelomaDilara Akcora-Yildiz, Nurbanu Gonulkirmaz, Tulin Ozkan, et al.
Leukemia & Lymphoma|September 14, 2004
Bone marrow microvessel density (MVD) in adult acute myeloid leukemia (AML): therapy induced changes and effects on survivalIsinsu Kuzu, Meral Beksac, Mutlu Arat, et al.
Respirology (Carlton, Vic.)|November 8, 2007
High CD95 expression of BAL lymphocytes predicts chronic course in patients with sarcoidosisOzlem Kumbasar Ozdemir, Gokhan Celik, Klara Dalva, et al.
Molecular Biology Reports|December 14, 2022
Werner helicase is required for proliferation and DNA damage repair in multiple myelomaDilara Akcora-Yildiz, Tulin Ozkan, Mehmet Ozen, et al.
Haematologica|December 6, 2006
Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myelomaKa Lung Wu, Meral Beksac, Jan van Droogenbroeck, et al.
Annals of Hematology|October 6, 2011
Case-matched comparison with standard versus reduced intensity conditioning regimen in chronic myeloid leukemia patientsPervin Topcuoglu, Mutlu Arat, Muhit Ozcan, et al.
Leukemia & Lymphoma|June 14, 2003
The detection of flow cytometric G-CSF receptor expression and it's effect on therapy in acute myeloid leukemiaSim Kutlay, Meral Beksac, Klara Dalva, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 21, 2006
Does continuous flow apheresis influence viability in allogeneic hematopoietic stem cell harvest?Sule Mine Bakanay, Klara Dalva, Mutlu Arat, et al.
Dermatology (Basel, Switzerland)|February 21, 2008
Vitiligo after hematopoietic cell transplantation: six cases and review of the literatureHatice Sanli, Bengu Nisa Akay, Mutlu Arat, et al.
Pageof 19